Seems a stalemate with everyone out who can't see any future, and the stronger hands who can. The market for BNC210 is still worth billions of dollars, and we've got positive Phase IIa results in GAD. PTSD was a bust, so BNO will stop any effort on that front.
Agitation trial result read out in Q1 2019. Market for that alone is US$1.6B per year. Success would be game changing for current shareholders.
Trouble is if the Agitation results are not favorable, there are no positives on the horizon. Board will therefore see it strategic to conduct a CR before the Agitation results are released. Likely moves in this direction will occur after the strategic review, with results of the review given at the AGM.
Share price very depressed at these levels. I'd imagine no further trials for BNC210 no matter the Agitation trial results. Need favorable results and a partner to bring it to a Phase 3 trial.
Given I bought in at 29c, and believe the Agitation results will be positive, I am hanging on to my shares. If your not a holder, I would wait till the Agitation results. CR in the mean time won't be large and has to be weathered.
All IMHO, GLTAH, DYOR.
BNO Price at posting:
19.0¢ Sentiment: Hold Disclosure: Held
